Chronic pain is notoriously difficult to treat, and it has a wide-reaching impact on both the peripheral and central nervous systems, which can in turn impact emotional, sensory, and cognitive functions, and have an adverse effect on an individual’s overall well-being. Certain classic psychedelics, such as LSD and magic mushrooms, might provide some potential for managing chronic pain, as well as dealing with mental health conditions such as depression or anxiety (although these are both often interwoven with chronic pain due to the long-term effects on one’s mental health).
Despite the attention being largely focused on utilising the benefits of psychedelics for managing mental health, there has been growing interest in the potential of these substances for managing pain conditions, which dates back all the way to the 1930s, according to the Psychedelics and Pain Association. Even as far back as the late 1800s, there have been studies to suggest that mescaline (in the form of peyote) was beneficial for managing pain conditions and phantom limb issues. According to the PPA, this research dropped off in the 1960s due to restrictions; however, since the early 2000s and more so in the 2020s, there has been increasing research in exploring how psychedelics might be beneficial for managing pain.
The benefits from these substances may even occur on a subtle level, and individuals might find some pain relief from consuming sub-psychedelic doses. There has been some research into the self-administered use of microdoses of psilocybin mushrooms by individuals who shared common experiences of reduced quality of life, along with difficulties using existing medications to manage their conditions. Even with the low doses being used in this particular instance, people have been experiencing the analgesic benefits of psilocybin, and this has been complemented by introducing exercise into the mix.
Further research into cluster headaches has shown psilocybin to be promising for managing this condition, with individuals experiencing a reduction of approximately 50% in the frequency of attacks after a pulse administration of psilocybin (10 mg/70 kg, 3 doses, 5 days apart each).
Some research also suggests that LSD can be utilised for managing pain, with an analgesic effect at doses low enough to not induce a psychedelic experience (20 μg). The promising analgesic effects of LSD were known about in the 1950s, where it was discovered to be particularly beneficial for managing certain types of headaches, such as migraines, before being shown in the early 1960s to help with managing cluster headaches. A “cluster” is the period in which the individual is experiencing a regular occurrence of attacks, ranging from weeks to years, where there might be some unpredictability. Patients may experience some remission, but about 15–20% of cluster headache patients experience this as a chronic condition, with only brief or no remission periods at all. As this condition wasn’t properly defined until the 1980s, it has made evidence surrounding the benefit of psychedelics for managing it somewhat unclear; however, there has been renewed interest since the early 2000s in exploring the benefit of psychedelics for managing this debilitating condition.
Psychedelics might provide a useful avenue for these kinds of conditions, which are difficult to define or poorly understood, and interestingly, there has been some recent research to suggest that the use of psilocybin and other classic psychedelics might be useful for managing fibromyalgia. As I have personally experienced the benefits of mushrooms in helping me manage this condition, it’s important to see the scientific research catching up with the anecdotal reports.
share your toughts
Join the Conversation.
psychedelics are fascinating